Regulus Therapeutics
- Pharmaceutical Preparations
- San Diego, California
Compensation history
Top executives at Regulus Therapeutics received an average of $2M per person in annual compensation from 2011 to 2021.
Average pay of disclosed executives at Regulus Therapeutics
By year
Executives
We found 11 executives who work or worked at Regulus Therapeutics.
Joseph Hagan
Regulus Therapeutics
Chief Executive Officer
Christopher Aker
Regulus Therapeutics
General Counsel
Cris Calsada
Regulus Therapeutics
Chief Financial Officer
Daniel Chevallard
Regulus Therapeutics
Chief Financial Officer
Timothy Wright
Regulus Therapeutics
Chief Research & Development Officer
Mark Deeg
Regulus Therapeutics
Chief Medical Officer
Paul Grint
Regulus Therapeutics
Chief Executive Officer
Kleanthis Xanthopoulos
Regulus Therapeutics
Chief Executive Officer
News
Regulus Therapeutics CEO Joseph Hagan's 2021 pay falls 22% to $1.8M
April 27, 2022
Regulus Therapeutics CEO Joseph Hagan's 2020 pay rises 16% to $2.3M
April 30, 2021
Regulus Therapeutics CEO Joseph Hagan's 2019 pay slips 14% to $2M
April 29, 2020
Regulus Therapeutics CEO Joseph Hagan's 2018 pay jumps 22% to $2.3M
July 1, 2019
About Regulus Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address4224 Campus Point Court, Suite 210, San Diego, California 92121
- Phone858-202-6300
- Fiscal year endDecember 31
Source: SEC filings on April 27, 2022, April 30, 2021, April 29, 2020, July 1, 2019, April 20, 2018, April 28, 2017, April 22, 2016, April 30, 2015, and April 30, 2013.